PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation

PRCT·NASDAQ

$26.33

-1.6%
HealthcareMedical - Devices

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

At a Glance

Live Snapshot
Market Cap$1.50B
EPS-1.7200
P/E Ratio-15.31
Earnings Date08/05/2026

prct

Research Development Expenses

Last Annual Value

71.28M

3-Year CAGR

35%

5-Year CAGR

34%

10-Year CAGR

18%

PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation Competitors Analysis of research-development-expenses

PRCT · NASDAQ
Companyresearch-development-expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
71.28M
13.7%30.3%N/A 
3.69M
85.6%416.8%38.9%
0.00
N/AN/AN/A
186.20M
-9.0%14.2%N/A
80.28M
-9.1%3.1%16.0%
151.39M
18.5%36.3%N/A
30.99M
2.6%-2.7%8.7%
0.00
N/AN/AN/A
103.17M
-4.0%22.5%30.7%
PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corporation Fair Value Envelope

PRCT · NASDAQ

Our analysis suggests that PRCT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $26.33, this represents a potential HIDDEN relative to our calculated worth for PROCEPT BioRobotics Corporation.

Intrinsic Value
Current Price: $26.33